The Food and Drug Administration (FDA) has issued a Class II drug recall (D-0375-2026) for Dynarex BZK Antiseptic Towelettes manufactured for Dynarex Corporation. The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified in the manufacturing process. The affected product, NDC 67777-245-01, was distributed nationwide within the United States.

This recall signifies a significant compliance issue for the manufacturer, potentially impacting product efficacy or safety. Companies involved in drug manufacturing must ensure strict adherence to CGMP regulations to prevent similar recalls. While specific compliance actions for Dynarex Corporation are ongoing, the nature of a Class II recall suggests a potential for adverse events, necessitating prompt corrective actions by the manufacturer and awareness among distributors and healthcare providers regarding the affected product.